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The model of care in 
Freetown, Sierra Leone
I was placed with King’s Sierra Leone Partnership, 
which is based at the Connaught Hospital, the 
largest public sector hospital in Sierra Leone. They 
were working on health system strengthening long 
before Ebola arrived, and rapidly scaled up their efforts, including 
the hasty construction of an 18-bed Ebola holding unit (EHU) 
when the first Ebola virus disease (EVD) cases arrived in the city 
in May 2014. A further six smaller EHUs were then constructed at 
health facilities in and around the city. The aim of each unit was 
primarily to protect staff in other parts of the facility so that they 
could work as normally as possible. As such, all patients presenting 
for care, regardless of their symptoms, were first screened for 
EVD. Those who screened positive were moved to the EHU and 
the rest continued with care in the facility as usual. The screening 
algorithm had to be highly sensitive to prevent EVD patients 
progressing to the general facility, and it was therefore necessarily 
nonspecific. As a result 30 - 40% of patients admitted to the EHU 
did not have EVD, which raised some obvious concerns.[1] Most 
important was the need firstly to practise high-quality infection 
prevention and control between patients to prevent nosocomial 
transmission, and secondly to provide treatment for conditions 
that mimic EVD. Because there were no diagnostic tests at all, it 
was decided to give all patients antimalarials and ceftriaxone (in 
case of typhoid or other bacterial infections). It cuts against the 
grain of an antibiotic steward to use empirical treatment in this 
way, but this was no ordinary situation.
The clinical problem
Although EVD has always been considered a viral haemorrhagic 
fever, very little bleeding was seen during the current epidemic. 
Rather it proved to be a severe viral gastrointestinal illness with 
associated fever and thrombocytopenia,[2] so that fluid and electrolyte 
replacement was critical. Patients who were alert and orientated 
without vomiting could be encouraged to drink large volumes of oral 
rehydration solution, and intramuscular antiemetics could be used 
if needed. The decision to use intravenous fluids was hotly debated 
among the team I worked with. Proponents, including myself, pointed 
to the survival benefits that were likely to accrue from replacing 
lost volume and salts. Opponents had usually seen severe adverse 
events such as patients pulling out cannulas and bleeding profusely, 
constituting a high-level infection hazard and hastening death. We 
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deemed intravenous fluids to be contraindicated in patients who were 
agitated or confused or who bled excessively when blood was drawn. 
This group in fact had a very poor outlook, and we concentrated on 
palliative measures. Those in the middle ground, patients who were 
not confused and agitated but were struggling to keep up with oral 
fluids, were given intravenous therapy.
The mortality from EVD in West Africa is estimated at around 
60%. For foreign healthcare workers presenting to high-resource 
settings in the early stages it is close to 0%, and the ultimate reason 
for this is clearly resource availability. There is no good evidence 
that novel therapies such as Zmapp or convalescent plasma make 
a huge difference; rather, meticulous attention to detail regarding 
fluid and electrolyte balance, prompt recognition and treatment of 
secondary bacterial infection and a host of other basic interventions 
are important. In contrast to high-resource settings, the units I 
worked at were not able to test any blood parameters or even monitor 
temperature and blood pressure regularly. Fluid inputs and outputs 
could only be measured in the most rudimentary of ways. The 
average amount of time spent with a patient each day was around 
20 minutes, each minute spent wisely to tip the balance in favour of 
survival.
The working environment
Day-to-day work in an Ebola treatment unit did not draw heavily 
on my medical skills. Most tasks would normally be undertaken by 
nurses, cleaners or porters. A typical shift involved moving patients 
in and out of the unit, doing rounds with medication, fluids and 
food, and preparing corpses for the burial team by cleaning, bagging 
and carefully labelling them. Our team had a very flat hierarchy 
and included expatriate doctors and nurses alongside national staff 
who included fully qualified nurses, nursing students and hospital 
cleaners. There were very few Sierra Leonean doctors involved in the 
response.
The one area of work that did require some clinical skills was 
assessment of patients for admission to the unit. The screening 
algorithm was not perfect, and some patients with a negative screen 
clearly needed admission and testing while others, typically those 
with chronic illnesses including tuberculosis and HIV, might have 
screened positive but were in clear need of inpatient hospital care.
I was fortunate to be involved in a number of activities away from 
the hospital EHU. Most interesting was working on the development 
of smaller EHUs at satellite facilities. There was a constant need for 
training, supervision and encouragement, as these units lacked the 
institutional knowledge of a large tertiary hospital. Being able to keep 
these units running and therefore allow staff to continue with normal 
work was probably a major factor in preventing the Ebola epidemic 
from contributing to a total breakdown in the healthcare system that 
could have heralded secondary epidemics of vaccine-preventable 
diseases and increased mortality from malaria.
The research agenda
Away from the EHUs themselves, there was also research to be 
planned and carried out. VIP visitors were common, and I was 
fortunate to have face-to-face meetings with the heads of the Centers 
for Disease Control, the Wellcome Trust and the London School of 
Hygiene and Tropical Medicine, to name a few. We were involved 
in planning and discussing the ethics behind vaccine trials and 
evaluating a rapid point-of-care diagnostic test for Ebola,[3] all of 
which added to the experience. However, there was a frustration 
that research efforts were sometimes aimed at expensive high-tech 
solutions such as novel antivirals and convalescent plasma, when 
the basic standard of care, including low-tech solutions such as 
antidiarrhoeals and antibiotics, had not been optimised.[4]
Despite the dreadful nature of the disease and the immense 
suffering of the patients, from a personal perspective my visit to 
Freetown was extremely rewarding. As an infectious diseases doctor it 
was refreshing to be at the centre of such an important event.
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